Print

ImmunoCellular Therapeutics, Ltd to Present at 3rd Annual Cancer Immunotherapy Conference and 2012 Biotechnology Industry Organization (BIO) Investor Forum  
10/3/2012 10:38:03 AM

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced that Peter Ho, PhD, Director of Business Development, will present a company overview at 2:00 pm ET and participate in a panel discussion on advances in immunotherapy for glioma at 2:45 pm ET at the 3rd Annual Cancer Immunotherapy: A Long-Awaited Reality conference on Thursday, October 4, 2012, at the New York Academy of Medicine.
//-->